Tissue Microenvironment Modulation

Tissue microenvironment modulation refers to therapeutic strategies aimed at altering the cellular, molecular, and structural components of a tissue's microenvironment to affect disease processes. The microenvironment includes the extracellular matrix, stromal cells, immune cells, vasculature, and various signaling molecules. Modulating these components can impact tumor growth, tissue regeneration, inflammation, and therapeutic responsiveness. In oncology, for example, targeting the tumor microenvironment can involve depleting immunosuppressive cells, modifying extracellular matrix stiffness, altering cytokine/chemokine gradients, or reducing hypoxia, with the goal of enhancing anti-tumor immunity or improving drug delivery and efficacy[2][3][4][5][6][8]. However, these approaches often target multiple cell types and pathways rather than a single molecule or receptor, resulting in complexity and challenges such as toxicity, loss of tissue homeostasis, and compensatory mechanisms[6]. This concept is more accurately described as a therapeutic strategy than a classical drug target.

Other names

Tissue microenvironmentMicroenvironment modulation

Remodeling extracellular matrix; Altering immune cell infiltration; Modulating angiogenesis; Changing cytokine/chemokine milieu; Reducing hypoxia; Inducing apoptosis or immune surveillance; Reprogramming metabolism